Ultrapotent topical corticosteroids are the treatment of choice for vulvar lichen sclerosus patients My patient was diagnosed with lichen sclerosus on vulvar biopsy. What is the recommended treatment, ...

Please provide your email address to receive an email when new articles are posted on . At week 28, 88% of patients treated with combination therapy achieved 75% disease severity reduction vs. 47% on ...

Please provide your email address to receive an email when new articles are posted on . 92% of patients diagnosed prepuberty exhibited signs of active disease long-term. Nine patients were ...

The phase 3 trial DELTA CARE 1 will recruit up to 652 adult patients with lichen sclerosus (LS) to investigate the efficacy ...

Lipella Pharmaceuticals Inc. announced that the FDA has approved an Expanded Access Program for LP-310, an oral rinse formulated to treat oral lichen planus (OLP), a debilitating condition affecting ...

PITTSBURGH, April 23, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (LIPO) ("Lipella," "we," "our," or the "Company"), a clinical-stage biotechnology company focused on developing therapies ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...

BACKGROUND: Transcutaneous electrical nerve stimulation (TENS) has recently emerged as a possible effective treatment for pruritic dermatoses. Lichen simplex (LS) is one such condition, which may ...

DEAR DR. GOTT: I am an 80-year-old female diagnosed with lichen planus. Other than being told it is an autoimmune disease, the dentists and doctors I have visited have no idea what to do with me. I ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...